Carlos A. Guerrero-Bustamante

University of Pittsburgh — United States

Environmental Science · Physical Sciences

13h-index2.5kcitations22works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacteriophages and microbial interactions(20), Mycobacterium research and diagnosis(10), Microbial infections and disease research(9), Genomics and Phylogenetic Studies(5), RNA and protein synthesis mechanisms(5)

Publications22 total

Amplification, purification, and lyophilization of mycobacteriophages for therapeutic use
Microbiology Spectrum·2025Open Access
Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review
PHAGE·2025· 1 citedOpen Access
Comparative study on the virulence of mycobacteriophages
Journal of Virology·2025Open Access
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study
Journal of Cystic Fibrosis·2025· 1 citedOpen Access
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery
Virology Journal·2025· 4 citedOpen Access
Comparative study on the virulence of mycobacteriophages
2024Open Access
Bacteriophage tRNA-dependent lysogeny: requirement of phage-encoded tRNA genes for establishment of lysogeny
mBio·2024· 29 citedOpen Access
Mycobacterial nucleoid-associated protein Lsr2 is required for productive mycobacteriophage infection
Nature Microbiology·2023· 23 citedOpen Access
Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?
Respiration·2021· 33 cited
Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains
mBio·2021· 113 citedOpen Access
Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
mBio·2021· 77 citedOpen Access
CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering
Scientific Reports·2021· 67 citedOpen Access
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Nature Medicine·2019· 1.3k citedOpen Access
Yet More Evidence of Collusion: a New Viral Defense System Encoded by <i>Gordonia</i> Phage CarolAnn
mBio·2019· 53 citedOpen Access
Mycobacteriophage ZoeJ: A broad host-range close relative of mycobacteriophage TM4
Tuberculosis·2019· 44 cited
Bacteriophages of <i>Gordonia</i> spp. Display a Spectrum of Diversity and Genetic Relationships
mBio·2017· 172 citedOpen Access
Genome Sequences of Mycobacteriophages Kerberos, Pomar16, and StarStuff
Genome Announcements·2017· 3 citedOpen Access
Tales of diversity: Genomic and morphological characteristics of forty-six Arthrobacter phages
PLoS ONE·2017· 43 citedOpen Access
Prophage-mediated defence against viral attack and viral counter-defence
Nature Microbiology·2017· 281 citedOpen Access
Complete Genome Sequences of 38 <i>Gordonia</i> sp. Bacteriophages
Genome Announcements·2017· 7 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Graham F. Hatfull(20), Rebecca A. Garlena(12), Deborah Jacobs‐Sera(11), Daniel A. Russell(10), Rebekah M. Dedrick(8), Welkin H. Pope(4), Matthew T. Montgomery(4), Krista G. Freeman(4), Rhea N. Coler(4), Sasha E. Larsen(4), Travis N. Mavrich(3), J. Alfred Bonilla(3), Karen K. Klyczek(3), Reinhard Vehring(3), Tamarah L. Adair(2), Lee E. Hughes(2), Margaret A. Kenna(2), Catherine M. Mageeney(2), Marie C. Pizzorno(2), Michael R. Rubin(2)